[PDF][PDF] Prise en charge clinique de la COVID-19: orientations évolutives, 13 janvier 2023

O mondiale de la Santé - 2023 - apps.who.int
L'affection post-COVID-19 survient chez des personnes présentant des antécédents
d'infection probable ou confirmée par le SARS-CoV-2, généralement trois mois après …

[HTML][HTML] Making respiratory care safe for neonatal and paediatric intensive care unit staff: mitigation strategies and use of filters

BG Carter, E Harcourt, A Harris, M Zampetti… - Canadian Journal of …, 2024 - ncbi.nlm.nih.gov
Background Many medical devices in pediatric and newborn intensive care units can
potentially expose healthcare workers (HCWs) and others to transmission of respiratory and …

Role of Monoclonal Antibodies for the Management of Immersing Variant of SARS-CoV-2

VP Chavda, HK Solanki, SC Chauhan… - SARS-CoV-2 Variants …, 2024 - taylorfrancis.com
The new coronavirus disease 2019 (COVID-19) pandemic was triggered by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are no globally accessible …

[HTML][HTML] Gasless laparoendoscopic single-site surgery for management of unruptured tubal pregnancy in a woman with moderate COVID-19 pneumonia after …

S Hayashi, A Takeda - Case Reports in Women's Health, 2022 - Elsevier
Background Diagnostic and therapeutic challenges may arise in the management of
gynecologic emergencies, such as ectopic pregnancy, for women with severe acute …

[PDF][PDF] Stellungnahme der DGPI, API, DGKJ, DGPK, GPOH, GKJR, GPP und STAKOB zur Klinik, Diagnostik und Therapie von Kindern mit COVID-19-Update Februar …

T Tenenbaum, M Hufnagel, M Knuf, PDR Kobbe… - dgpi.de
Die DGPI hat am 24.11. 2020 gemeinsam mit der GPP, API, GKJR, DGPK sowie in
Zusammenarbeit mit dem Ständigen Arbeitskreis der Kompetenz-und Behandlungszentren …

[PDF][PDF] Traitements contre la COVID-19: orientations évolutives, 7 décembre 2021

O mondiale de la Santé - 2021 - apps.who.int
Plus de 251 millions de cas confirmés de COVID-19 avaient été comptabilisés au 10
novembre 2021 (10). La pandémie a fait jusqu'à présent plus de 5, 1 millions de morts (10) …

Profile of COVID-19 patients in Dr. Moewardi Hospital Surakarta Indonesia

C Hadi, C Pramana - Open Access Macedonian Journal of Medical …, 2021 - oamjms.eu
BACKGROUND: The 2019 coronavirus disease has been declared by WHO as a pandemic
that has spread throughout the world since March 2020. AIM: This study was conducted to …

Intensification of cell clarification in monoclonal antibody manufacturing

M Saballus - 2022 - repo.uni-hannover.de
Monoklonale Antikörper (mAb) ermöglichen die Behandlung einer Vielzahl schwerer,
chronischer Erkrankungen, wie bestimmte Formen von Krebs und Rheuma, weshalb stetig …

Fluticasone propionate as a potential treatment for COVID-19.

MW McCarthy - Drugs of Today (Barcelona, Spain: 1998), 2022 - europepmc.org
Outpatient treatment options for mild to moderate COVID-19 are severely limited. While
many therapeutic options have been proposed, very few have demonstrated the appropriate …

Characteristics of living systematic review for COVID-19

Z Chen, J Luo, S Li, P Xu, L Zeng, Q Yu… - Clinical …, 2022 - Taylor & Francis
Purpose The systematic review aims to analyze and summarize the characteristics of living
systematic review (LSR) for coronavirus disease 2019 (COVID-19). Methods Six databases …